Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
14 pending office actions • 10 art units • 13 examiners • 3 of 14 (21%) have an AI response strategy ready • 21 patents granted in the last 365 days
Bausch + Lomb Ireland Limited is currently navigating 15 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 13 distinct examiners, showing that the company's pharmaceutical developments are being reviewed by an array of patent office personnel. Furthermore, the portfolio spans 10 distinct art units, which indicates departmental diversity. This suggests that the company's intellectual property intersects with 10 different specialized scientific and technical categories within the biotechnology sector.
BLEDSOE, JOSHUA CALEB is the busiest examiner for the portfolio, with 2 pending office actions under his review. Despite this, the overall prosecution effort is decentralized, as 13 distinct examiners are involved in the 15 pending actions. This distribution requires the company to manage various examiner styles and art unit requirements simultaneously. The presence of 10 distinct art units suggests that the legal strategy must be adaptable to the specific precedents and guidelines of each individual examination group while managing the 2 actions pending with the busiest examiner.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (36%) |
| §112 only | 1 (7%) |
| Double-patenting + other | 1 (7%) |
| Multi-statute (no §101) | 7 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DELCOTTO, GREGORY R | 2 | 54.0% | +75.8% |
| CHEUNG, CHUN HOI | 1 | 62.4% | +39.2% |
| MARCETICH, ADAM M | 1 | 72.7% | +18.8% |
| SPAMER, DONALD R | 1 | 59.2% | +32.1% |
| WARD, PAUL V | 1 | 83.2% | -12.2% |
| BLEDSOE, JOSHUA CALEB | 1 | 44.4% | +52.7% |
| MAHADEVAN, JANAKI ANANTH | 1 | — | — |
| KIM, CRAIG SANG | 1 | 86.3% | +9.8% |
| CARPENTER, WILLIAM R | 1 | 54.4% | +52.6% |
| MCMILLIAN, KARA RENITA | 1 | 30.7% | +37.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18377451 | Infusion Sleeve For Phacoemulsification | KIM, CRAIG SANG | 9d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18376693 | NEEDLE FOR ATTACHMENT TO OPHTHALMIC SURGICAL HANDPIECES | CARPENTER, WILLIAM R | 16d overdue |
| 18355907 | OPHTHALMIC LENS INCLUDING A SPATIALLY-MODULATED OPTICAL POWER PROFILE | RAKOWSKI, CARA E | 61d |
| 19054362 | CONTACT LENS BLISTER PACKAGING ARRANGEMENT AND METHODS | CHEUNG, CHUN HOI | — |
| 18862267 | VENTED MULTI-DOSE OCULAR FLUID DELIVERY SYSTEM | MARCETICH, ADAM M | — |
| 18786806 | PACKAGING SOLUTIONS | SPAMER, DONALD R | — |
| 18597497 | METHODS FOR TREATING OCULAR SURFACE PAIN | WARD, PAUL V | — |
| 18506909 | HYDRATION FORMULATION | MAHADEVAN, JANAKI ANANTH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18376693 | NEEDLE FOR ATTACHMENT TO OPHTHALMIC SURGICAL HANDPIECES | CARPENTER, WILLIAM R | 16d overdue |
| 18365019 | OPHTHALMIC COMPOSITION COMPRISING AN ANTI-ALLERGEN AND A REDNESS REDUCTION AGENT | MCMILLIAN, KARA RENITA | 48d |
| 19054362 | CONTACT LENS BLISTER PACKAGING ARRANGEMENT AND METHODS | CHEUNG, CHUN HOI | — |
| 18862267 | VENTED MULTI-DOSE OCULAR FLUID DELIVERY SYSTEM | MARCETICH, ADAM M | — |
| 18786806 | PACKAGING SOLUTIONS | SPAMER, DONALD R | — |
| 18422186 | MONOFUNCTIONAL SILICONE MONOMERS AND SILICONE HYDROGELS FORMED THEREFROM | BLEDSOE, JOSHUA CALEB | — |
| 18374211 | CONTACT LENS TREATING SOLUTION | DELCOTTO, GREGORY R | — |
| 18374208 | CONTACT LENS TREATING SOLUTION | DELCOTTO, GREGORY R | — |
| Art Unit | Apps |
|---|---|
| 1693 | 2 |
| 1761 | 2 |
| 3736 | 1 |
| 1622 | 1 |
| 1762 | 1 |
| 3741 | 1 |
| 3783 | 1 |
| 1623 | 1 |
| 2872 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19054362 | CONTACT LENS BLISTER PACKAGING ARRANGEMENT AND METHODS | CHEUNG, CHUN HOI | 3736 | §103§112 | Final Rejection | — | Pending | Feb 14, 2025 |
| 18862267 | VENTED MULTI-DOSE OCULAR FLUID DELIVERY SYSTEM | MARCETICH, ADAM M | — | §103§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18786806 | PACKAGING SOLUTIONS | SPAMER, DONALD R | — | §102§103§112 | Final Rejection | — | Pending | Jul 29, 2024 |
| 18597497 | METHODS FOR TREATING OCULAR SURFACE PAIN | WARD, PAUL V | 1622 | §102§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18422186 | MONOFUNCTIONAL SILICONE MONOMERS AND SILICONE HYDROGELS FORMED THEREFROM | BLEDSOE, JOSHUA CALEB | 1762 | §112 | Final Rejection | — | Pending | Jan 25, 2024 |
| 18506909 | HYDRATION FORMULATION | MAHADEVAN, JANAKI ANANTH | 1693 | §102§103§112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18377451 | Infusion Sleeve For Phacoemulsification | KIM, CRAIG SANG | 3741 | §103 | Final Rejection | 9d | Pending | Oct 06, 2023 |
| 18376693 | NEEDLE FOR ATTACHMENT TO OPHTHALMIC SURGICAL HANDPIECES | CARPENTER, WILLIAM R | 3783 | §102§103 | Final Rejection | 16d overdue | Pending | Oct 04, 2023 |
| 18374211 | CONTACT LENS TREATING SOLUTION | DELCOTTO, GREGORY R | 1761 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18374208 | CONTACT LENS TREATING SOLUTION | DELCOTTO, GREGORY R | 1761 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18365019 | OPHTHALMIC COMPOSITION COMPRISING AN ANTI-ALLERGEN AND A REDNESS REDUCTION AGENT | MCMILLIAN, KARA RENITA | 1623 | §103 | Non-Final OA | 48d | AI Ready | Aug 03, 2023 |
| 18355907 | OPHTHALMIC LENS INCLUDING A SPATIALLY-MODULATED OPTICAL POWER PROFILE | RAKOWSKI, CARA E | 2872 | §102§103 | Non-Final OA | 61d | Pending | Jul 20, 2023 |
| 17905924 | COMPOSITIONS AND METHODS FOR EYE HEAL TH COMPRISING AREDS AND VITAMIN B COMPLEX | SAEED, ALI S | 1616 | §103§112DP | Non-Final OA | 1d overdue | AI Ready | Sep 08, 2022 |
| 17905913 | COMPOSITIONS AND METHODS FOR AGE RELATED EYE DISEASES COMPRISING HIGH CONCENTRATIONS OF VITAMINS | GALSTER, SAMUEL LEONARD | 1693 | §103Other | Final Rejection | 53d | AI Ready | Sep 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial